Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Kidney Failure, Chronic,Anemia,Cancer,Blood Transfusion, Autologous, Date of authorisation: 16/07/1997, Revision: 28, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):